Overall, our findings suggest that loss of ANGPTL4 promotes (visceral) obesity yet, by raising insulin levels, reduces glucose intolerance, and that this effect is partly dependent on the gut bacteria. The gene discussed is ANGPTL4; the disease is obesity due to melanocortin 4 receptor deficiency.